Scimee(SZ:300425)2023-10-26 16:00Financial Performance - The company's revenue for Q3 2023 was ¥266,838,130.61, representing a year-on-year increase of 4.85%[4] - The net profit attributable to shareholders for Q3 2023 was -¥2,953,716.50, with a year-to-date net profit of ¥45,282,915.22, down 16.65% compared to the previous year[4] - The basic earnings per share for Q3 2023 was -¥0.0044, a decrease of 16.67% year-on-year[4] - Total operating revenue for the third quarter reached ¥862,297,377.65, an increase of 5.9% compared to ¥817,684,924.34 in the same period last year[21] - Net profit for the quarter was ¥46,262,899.99, a decrease of 24.8% from ¥61,575,893.73 in the previous year[23] - Earnings per share (EPS) decreased to ¥0.0670 from ¥0.0804, representing a decline of 16.8%[24] Assets and Liabilities - The total assets at the end of Q3 2023 were ¥4,125,059,058.56, a decrease of 0.50% from the end of the previous year[4] - The company's total liabilities were reported at CNY 2,284,619,963.92, compared to CNY 2,235,083,728.06 in the previous quarter, indicating a growth of approximately 2.2%[18] - The company's total liabilities decreased to ¥1,782,766,415.74 from ¥1,817,155,398.37, a reduction of 1.9%[20] - Non-current liabilities decreased to ¥408,284,987.77 from ¥489,292,490.00, showing a decline of 16.5%[20] - The total equity attributable to shareholders was ¥2,178,980,339.54, reflecting a 0.65% increase from the previous year[5] - The total equity attributable to shareholders of the parent company increased to ¥2,178,980,339.54 from ¥2,164,928,757.91, reflecting a growth of 0.6%[20] Cash Flow - The cash flow from operating activities for the year-to-date period increased by 102.32% to ¥70,930,785.56[4] - Cash inflow from operating activities totaled ¥837,529,319.58, compared to ¥785,750,684.95 in the same period last year, indicating a growth of 6.6%[24] - The net cash flow from operating activities for Q3 2023 was CNY 70,930,785.56, an increase of 102.5% compared to CNY 35,059,185.77 in Q3 2022[26] - The total cash outflow from investing activities was CNY 71,368,308.87, down 46% from CNY 132,307,316.33 in the same period last year[26] - The net cash flow from financing activities was -CNY 52,949,288.87, slightly improved from -CNY 55,714,882.52 in Q3 2022[27] - The cash inflow from financing activities was CNY 265,040,200.60, down 33.6% from CNY 399,095,672.35 in the previous year[26] Investments and Expenses - Financial expenses increased by 134.90% to ¥17,236,993.45, primarily due to unrealized financing income and reduced interest capitalization[9] - The company experienced a 304.19% increase in investment income, amounting to ¥5,832,293.12, attributed to dividends from other non-current financial assets[9] - Research and development expenses were ¥22,805,363.73, down from ¥29,592,162.93, indicating a decrease of 22.9%[21] - The company reported an investment income of ¥5,832,293.12, significantly higher than ¥1,442,964.95 from the previous year, marking an increase of 304.5%[21] Operational Highlights - The company has strengthened its market marketing and accounts receivable recovery, leading to improved new contract amounts and revenue[8] - The company did not report any new product launches or significant market expansions during this quarter[27] Inventory and Receivables - Accounts receivable stood at CNY 1,431,446,759.55, showing a marginal decrease from CNY 1,434,634,499.43 in the previous quarter[18] - Inventory increased to CNY 390,407,480.87 from CNY 312,164,918.85, indicating a growth of approximately 25.1%[18] - The company's contract liabilities increased to CNY 116,172,523.05 from CNY 68,462,976.18, marking a significant rise of approximately 69.5%[19] - The company reported a significant increase in contract assets to CNY 127,687,282.98 from CNY 89,347,750.49, reflecting a growth of approximately 43%[18]